TIANYIN PHARMACEUTICAL
TPI
TPI was delisted on the 29th of April, 2016.
8 hedge funds and large institutions have $4.57M invested in TIANYIN PHARMACEUTICAL in 2013 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
33% more funds holding
Funds holding: 6 → 8 (+2)
5% more capital invested
Capital invested by funds: $4.37M → $4.57M (+$203K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$71.8K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$41.2K |
| 3 |
SIM
Spark Investment Management
New York
|
+$37.4K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$13.6K |
| 5 |
BWFA
Baltimore-Washington Financial Advisors
Columbia,
Maryland
|
+$4.68K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PAM
1
Pope Asset Management
Memphis,
Tennessee
| $4.08M | -$131K | -142,350 | -3% |
|
|
2
Renaissance Technologies
New York
| $387K | +$71.8K | +78,200 | +19% |
|
|
VKH
3
Virtu KCG Holdings
New York
| $35K | +$41.2K | +44,897 | New |
|
|
SIM
4
Spark Investment Management
New York
| $32K | +$37.4K | +40,700 | New |
|
|
RIM
5
Regent Investment Management
Louisville,
Kentucky
| $19K | -$7.16K | -7,800 | -24% |
|
|
6
Citadel Advisors
Miami,
Florida
| $12K | +$13.6K | +14,803 | New |
|
|
BWFA
7
Baltimore-Washington Financial Advisors
Columbia,
Maryland
| $4K | +$4.68K | +5,100 | New |
|
|
U
8
UBS
Zurich,
Switzerland
| $2K | -$6.13K | -6,678 | -68% |
|
|
CCB
9
Cutter & Co Brokerage
Ballwin,
Missouri
| – | -$52K | -69,500 | Closed |
|
|
FA
10
Financial Advantage
Columbia,
Maryland
| – | -$1K | -1,000 | Closed |
|
TPI Hedge Fund Activity: Q4 2013 in Review
8 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in TIANYIN PHARMACEUTICAL (TPI) for Q4 2013, worth a combined $4.57M — up 4.6% from $4.37M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new TPI positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $71.8K. The largest seller was Pope Asset Management, cutting an estimated $131K.
- 8 institutional investors held TIANYIN PHARMACEUTICAL (TPI) as of Q4 2013, up from 6 in Q3 2013.
- Funds reported $4.57M of TIANYIN PHARMACEUTICAL stock for Q4 2013, up 4.6% quarter-over-quarter.
- 4 funds opened new TIANYIN PHARMACEUTICAL positions in Q4 2013 and 2 closed out, a net change of +2 holders.
- The largest TIANYIN PHARMACEUTICAL buyer in Q4 2013 was Renaissance Technologies, an estimated $71.8K added.
- The largest TIANYIN PHARMACEUTICAL seller in Q4 2013 was Pope Asset Management, an estimated $131K sold.
Based on aggregated 13F filings for Q4 2013.